News

  1. All post
  2. News
  3. Press release
Press release

Atransen Pharma Selected for the “Nakanoshima Qross Drug Discovery Cluster Campus Development Project” and Chosen for the “Overseas Ecosystem Bridge Support” Program

News

Dr. Yoshikatsu Kanai’s BNCT Project with APL1202 Selected for AMED’s FY2025 P‑PROMOTE Program

News

Atransen Pharma Raises JPY 1.13 Billion in Series A Funding

News

APL1101 Selected for AMED’s Strengthening Program for Pharmaceutical Startup Ecosystem

News

Atransen Pharma CSO and the collaboration team Unveil LAT1 Structural Insights in Nature Communications

News

MOU Signed to Advance Research and Development Initiatives

Load more
LOADING...
News

Dr. Yoshikatsu Kanai’s BNCT Project with APL1202 Selected for AMED’s FY2025 P‑PROMOTE Program

News

Atransen Pharma Raises JPY 1.13 Billion in Series A Funding

News

APL1101 Selected for AMED’s Strengthening Program for Pharmaceutical Startup Ecosystem

News

Atransen Pharma CSO and the collaboration team Unveil LAT1 Structural Insights in Nature Communications

News

MOU Signed to Advance Research and Development Initiatives

News

we have launched our official website.

Load more
LOADING...
Press release

Atransen Pharma Selected for the “Nakanoshima Qross Drug Discovery Cluster Campus Development Project” and Chosen for the “Overseas Ecosystem Bridge Support” Program